Business Description
![Exicure Inc Exicure Inc logo](https://static.gurufocus.com/logos/0C0000BCOK.png?14)
Exicure Inc
NAICS : 325411
SIC : 2834
ISIN : US30205M1018
Description
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.21 | |||||
Debt-to-Equity | 2.94 | |||||
Debt-to-EBITDA | -0.53 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -28.89 | |||||
Beneish M-Score | -13.44 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 37.1 | |||||
3-Year EPS without NRI Growth Rate | 40.7 | |||||
3-Year FCF Growth Rate | 55.4 | |||||
3-Year Book Growth Rate | -74.5 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.51 | |||||
9-Day RSI | 39.94 | |||||
14-Day RSI | 39.75 | |||||
6-1 Month Momentum % | -10.73 | |||||
12-1 Month Momentum % | -56.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.55 | |||||
Quick Ratio | 0.55 | |||||
Cash Ratio | 0.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -43.6 | |||||
Shareholder Yield % | 23.1 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -2074.6 | |||||
Net Margin % | -2667.2 | |||||
FCF Margin % | -1497.8 | |||||
ROE % | -195.77 | |||||
ROA % | -86.89 | |||||
ROIC % | -87.85 | |||||
ROC (Joel Greenblatt) % | -174.5 | |||||
ROCE % | -102.34 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.43 | |||||
PB Ratio | 1.24 | |||||
Price-to-Tangible-Book | 1.21 | |||||
EV-to-EBIT | -0.66 | |||||
EV-to-EBITDA | -0.73 | |||||
EV-to-Revenue | 17.71 | |||||
EV-to-FCF | -1.18 | |||||
Earnings Yield (Greenblatt) % | -151.52 | |||||
FCF Yield % | -274.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:XCUR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Exicure Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.5 | ||
EPS (TTM) ($) | -1.52 | ||
Beta | 0.71 | ||
Volatility % | 65.49 | ||
14-Day RSI | 39.75 | ||
14-Day ATR ($) | 0.044072 | ||
20-Day SMA ($) | 0.346348 | ||
12-1 Month Momentum % | -56.02 | ||
52-Week Range ($) | 0.3 - 1.47 | ||
Shares Outstanding (Mil) | 8.65 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Exicure Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Exicure Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Exicure Inc Frequently Asked Questions
What is Exicure Inc(XCUR)'s stock price today?
The current price of XCUR is $0.32. The 52 week high of XCUR is $1.47 and 52 week low is $0.30.
When is next earnings date of Exicure Inc(XCUR)?
The next earnings date of Exicure Inc(XCUR) is 2024-08-09 Est..
Does Exicure Inc(XCUR) pay dividends? If so, how much?
Exicure Inc(XCUR) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |